T1	Participants 81 121	patients with resectable gastric cancer:
T2	Participants 329 382	386 Japanese patients with resectable gastric cancer.
T3	Participants 491 535	264 patients with curatively resected cancer
T4	Participants 760 772	264 patients
T5	Participants 1028 1078	patients with a curatively resected gastric cancer
